EcoDrugPlus


Synonyms	Butamben Butesin Butyl aminobenzoate Butyl p-aminobenzoate Butyl paba NSC-128464 P-aminobenzoic acid butyl ester
Status
Molecule Category	Free-form
UNII	EFW857872Q
EPA CompTox	DTXSID7022417

Datasets:

Active Pharmaceutical Ingredients

Bioactive chemicals

Agrochemicals

Human Metabolites

Search:

Exact

Similarity

SubStructure


InChI Key	IUWVALYLNVXWKX-UHFFFAOYSA-N
Smiles	CCCCOC(=O)c1ccc(N)cc1
InChI	InChI=1S/C11H15NO2/c1-2-3-8-14-11(13)9-4-6-10(12)7-5-9/h4-7H,2-3,8,12H2,1H3

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C11H15NO2
Molecular Weight	193.25
AlogP	2.23
Hydrogen Bond Acceptor	3.0
Hydrogen Bond Donor	1.0
Number of Rotational Bond	4.0
Polar Surface Area	52.32
Molecular species	NEUTRAL
Aromatic Rings	1.0
Heavy Atoms	14.0

Mechanism of Action	Action	Reference
Transient receptor potential cation channel subfamily A member 1 inhibitor	INHIBITOR	PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed

Targets	EC50(nM)	IC50(nM)	Kd(nM)	Ki(nM)	Inhibition(%)
Ion channel Voltage-gated ion channel Voltage-gated sodium channel	-	-	-	-	7-36.8
Transporter Electrochemical transporter SLC superfamily of solute carriers SLC21/SLCO family of organic anion transporting polypeptides	-	-	-	-	124.93-159.17

	EC50(nM)	IC50(nM)	Kd(nM)	Ki(nM)	Inhibition(%)
Cavia porcellus	-	-	-	-	7-36.8
Cricetulus griseus	-	-	-	-	124.93-159.17

Target Conservation


Protein: Transient receptor potential cation channel subfamily A member 1 Description: Transient receptor potential cation channel subfamily A member 1 Organism : Homo sapiens O75762 ENSG00000104321

Cross References

Resources	Reference
ChEBI	3231
ChEMBL	CHEMBL127516
DrugBank	DB11148
DrugCentral	3051
FDA SRS	EFW857872Q
KEGG	C07875
PubChem	2482
SureChEMBL	SCHEMBL81735
ZINC	ZINC000001530937


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

BUTAMBEN

Structure

Physicochemical Descriptors

Pharmacology

Target Conservation

Related Entries

Cross References